Aclaris Therapeutics, Inc. (ACRS) Total assets 2017–2025
Aclaris Therapeutics, Inc. (ACRS) total assets at each fiscal year-end, per SEC filings.
$160.5MFY2025 · since FY2017: $243.5M → $160.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $160.5M | -27.2% |
| FY2024 | $220.3M | +11.6% |
| FY2023 | $197.4M | -22.5% |
| FY2022 | $254.6M | +1.3% |
| FY2021 | $251.2M | +254.9% |
| FY2020 | $70.8M | -28.0% |
| FY2019 | $98.3M | -64.3% |
| FY2018 | $275.6M | +13.2% |
| FY2017 | $243.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ACRS financial trends
ACRS RevenueACRS Net incomeACRS Net marginACRS Gross profitACRS Gross marginACRS Operating incomeACRS Operating marginACRS Operating cash flowACRS Free cash flowACRS Capital expendituresACRS Return on equityACRS Stock buybacksACRS Dividends paidACRS Total liabilitiesACRS Shareholders’ equityACRS overview →